1. Introduction {#sec1}
===============

Rotator cuff tear is a common condition that causes pain and functional disability, and it has been reported that more than 50% of patients over the age of 60 years have a rotator cuff tear \[[@B1]\]. Surgical repair of rotator cuff tears is widely practiced and has been a commonly accepted treatment for full-thickness rotator cuff tears, especially when conservative treatment fails \[[@B2]\]. However, failure in rotator cuff healing remains one of the most common and well-known complications of surgical repair \[[@B3], [@B4]\]. Several factors associated with rotator cuff muscle changes, such as aging \[[@B5]\], apoptosis \[[@B6]\], muscle degeneration \[[@B7]\], sarcopenia \[[@B8]\], muscle atrophy \[[@B9]\], and muscle fatty infiltration \[[@B10]\], have been demonstrated to be associated with rotator cuff tear. Further, these anatomical and physiological rotator cuff muscle changes reportedly result in healing failure and poor functional outcomes after rotator cuff repair \[[@B11]--[@B13]\]. Various trials have been performed to improve the quality of rotator cuff muscles by using growth factors, platelet-rich plasma, stem cells or its secretome, and anabolic steroids \[[@B14]--[@B19]\]; however, only a few studies to identify the molecular mechanisms underlying changes in the rotator cuff muscle after a rotator cuff tear have been performed \[[@B10], [@B20]--[@B22]\].

Identification of gene expression patterns of rotator cuff muscle cells after a rotator cuff tear would be the first step and an important determinant in understanding the rotator cuff tear-related muscle changes and improving outcomes of rotator cuff repair surgery. Several studies have suggested various causes and mechanisms for muscle changes, such as atrophy and degeneration \[[@B9], [@B10], [@B21]--[@B25]\]; however, despite this, much remains unknown. Progression of muscle degeneration, atrophy, and fatty infiltration is usually caused by abnormal signaling processes in muscle cells \[[@B25]\]. Abnormal muscle cell activities are the results of external stimuli, such as physical damage or aging, which lead to differentiation into fat cells or fibrous tissue and ultimately myocyte destruction (instead of normal myocyte differentiation) \[[@B26]\]. Most of these cellular activities are directly related to intracellular gene regulation. Therefore, if we know how genes are regulated in muscle cells in response to external stimuli, it would be possible to understand the mechanism(s) underlying pathologic rotator cuff muscle changes after a rotator cuff tear. Further, this may also provide important information for the treatment of rotator cuff tears by controlling the expression of relevant genes. To date, only a few genes, such as those coding for peroxisome proliferator-activated receptors gamma (PPAR*γ*), CCAAT-enhancer-binding proteins alpha (CEBP*α*), myogenin, myostatin, and matrix metallopeptidases (MMPs), have been identified in relation to muscle changes after rotator cuff tears \[[@B20], [@B21], [@B24], [@B27]\]. However, to the best of our knowledge, a comprehensive analysis of the time-dependent changes in gene expression patterns after rotator cuff tears has not been reported.

Therefore, this study aimed to comprehensively analyze the patterns of gene expression in rotator cuff muscles with time after a rotator cuff tear (acute or chronic) by categorizing muscle physiology-related genes in a mouse model. In this study, we hypothesized that rotator cuff injury may cause alterations in gene expression regarding pathophysiology of rotator cuff muscle. Our study may improve understanding of molecular events after rotator cuff injury and may help the identification of novel regulation or control way to overcome the poor functional outcome after rotator cuff repair.

2. Materials and Methods {#sec2}
========================

2.1. Animal Experiment {#sec2.1}
----------------------

Eight-week-old male C57BL/6 mice (Orient Bio Inc., Seongnam, Korea) were used in this study. Before beginning the experiments, the mice were acclimatized to a 12:12-h light/dark cycle at 22 ± 2°C for 1 week and allowed unlimited access to food and water.

We generated the rotator cuff tear model in mice as described previously \[[@B10]\]. Briefly, the supraspinatus tendon of the right shoulder of each mouse was fully exposed and completely transected from the greater tuberosity of the humerus under anesthesia using Zoletile (30 mg/kg; Virbac, Carros, France) and Rompun (10 mg/kg; Bayer Korea Ltd., Seoul, Korea). The supraspinatus of the left shoulder served as a control. A 3-0 nylon suture was used to close the skin, and the mice were allowed unrestricted cage activity. At weeks 1 and 4 after the surgery, mice (n = 4 per time interval) were sacrificed by cervical dislocation, and the supraspinatus muscles of both shoulders were completely harvested from the scapular fossa. The muscle tissue samples were used for total RNA extraction. All animal experiments were approved by the Institutional Animal Care and Use Committee of the Konkuk University (IACUC: KU17122) and were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.

2.2. RNA and Gene Expression Profiling {#sec2.2}
--------------------------------------

RNA quality was assessed using Agilent 2100 Bioanalyzer (Agilent Technologies, USA), and its quantity was determined using the ND-1000 spectrophotometer (NanoDrop Technologies, USA). The total RNAs from each supraspinatus muscle at different phase (1 or 4 weeks) after injury were pooled and used for microarray. Gene expression analyses were performed using the global Affymetrix GeneChip® Human Gene 2.0 ST oligonucleotide arrays. About 300 ng of each RNA sample was used for the Affymetrix procedure, as recommended by the manufacturer (<http://www.affymetrix.com>). Briefly, 300 ng total RNA from each sample was converted to double-strand cDNA. Using a random hexamer incorporating a T7 promoter, amplified RNA (cRNA) was generated from the double-stranded cDNA template though an IVT (*in vitro* transcription) reaction and purified with the Affymetrix Sample Cleanup Module. cDNA was synthesized by random-primed reverse transcription using a dNTP mix containing dUTP. Next, cDNA was digested using the UDG and APE 1 restriction endonucleases, and end-labeled using the terminal transferase reaction incorporating a biotinylated dideoxynucleotide. The fragmented end-labeled cDNA was hybridized to the GeneChip® Human Gene 2.0 ST arrays for 16 h at 45°C and 60 rpm, as described in the Gene Chip Whole Transcript (WT) Sense Target Labeling Assay manual (Affymetrix). After hybridization, the chips were stained using Streptavidin Phycoerythrin (SAPE), washed in Genechip Fluidics Station 450 (Affymetrix), and scanned using Genechip Array Scanner 3000 7G (Affymetrix).

Ten gene categories that have direct or indirect effects on muscle physiology in relation to rotator cuff tears were selected. The categories were as follows: (1) aging, (2) inflammation, (3) apoptosis, (4) neovascularization, (5) extracellular matrix composition, (6) myocyte differentiation, (7) myocyte proliferation, (8) cellular migration, (9) fatty acid transport, and (10) muscle atrophy. Every gene expression values were measured, and among them, those with the fold change of rotator cuff tear group/control group were more than 2 or less than 1/2 with the raw values (log 2) of more than 4 were defined as significant genes and further analyzed. Especially, the aging-, apoptosis-, fatty acid transport-, and muscle atrophy-related categories were analyzed in detail because these categories are known to be closely associated with muscle changes, such as degeneration, fatty infiltration, and atrophy, after rotator cuff tear \[[@B10], [@B22], [@B23]\].

2.3. STRING Network {#sec2.3}
-------------------

The genes showing significant changes in expression were selected and used as the input for STRING (Search Tool for the Retrieval of Interacting Genes/Proteins; <https://string-db.org/>). Protein network analyses were performed. The database and web-tool STRING is a meta-resource that integrates most of the available information on protein--protein associations, and scores, weighs, and augments it with predicted interactions, as well as with the results of automatic literature mining searches \[[@B28]\]. Using this, we obtained the protein interaction network images associated with functional enrichment \[[@B29]\]. Information regarding the size of each node and edges between nodes is shown in [Figure 1](#fig1){ref-type="fig"} (EBIOGEN Inc., Korea).

2.4. Data Analysis {#sec2.4}
------------------

After the final washing and staining step, the Affymetrix GeneChip® Human Gene 2.0 ST oligonucleotide array was scanned using Affymetrix Model 3000 G7 Scanner and the image data was extracted using the Affymetrix Commnad Console software v1.1. The raw.cel file generated after the above procedure showed the expression intensity data and was used for the next step. Expression data were generated by the Affymetrix Expression Console software version 1.1. For normalization, the Robust Multi-Average (RMA) algorithm implemented in the Affymetrix Expression Console software was used. In order to find the coexpressing gene groups (which had similar expression patterns), we performed hierarchical clustering in the MultiExperiment Viewer software v4.4 (MEV; [www.tm4.org](http://www.tm4.org)). The web-based tool DAVID (Database for Annotation, Visualization, and Integrated Discovery; <http://david.abcc.ncifcrf.gov/home.jsp>) was used to perform biological interpretation for the differentially expressed genes. Next, these genes were classified based on the information about their functions in Gene Ontology in the KEGG Pathway database.

2.5. Quantitative Reverse Transcription (qRT) PCR Analysis {#sec2.5}
----------------------------------------------------------

To validate the gene expression analysis results obtained using the microarray process described above, we performed qRT-PCR analysis for several representative genes. Total RNA was extracted from the supraspinatus muscles using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA), according to the manufacturer\'s instructions, and used for cDNA synthesis using the Maxime RT PreMix kit (iNtRON Biotechnology, Korea). The qRT-PCR analysis was carried out using Light Cycler 480 System (Roche Diagnostics, Swiss) with 2 × qPCR BIO SyGreen Mix Lo-ROX (PCR Biosystems, London, UK). All expression data were normalized to actin expression.

2.6. Statistical Analysis {#sec2.6}
-------------------------

Descriptive statistics were used to present the analyzed data in this study.

3. Results {#sec3}
==========

A total of 39,429 genes were analyzed. Among these, 9,696 genes were associated with muscle physiology. Significant changes in expression were observed for 12,178 genes during the acute phase and 2,370 genes during the chronic phase. The number and distribution of genes expressed per category are shown in [Figure 2](#fig2){ref-type="fig"} and [Table 1](#tab1){ref-type="table"}.

From the Venn diagram of genes showing significantly different expression at weeks 1 and 4 after the rotator cuff tear, we could identify 115 genes which showed a reverse expression pattern (genes that increased during the acute phase but decreased during the chronic phase or genes that decreased during the acute phase but increased during the chronic phase) ([Figure 3](#fig3){ref-type="fig"}).

Overall, the most highly expressed gene at week 1 was keratin 18, which increased 217.8 times compared to the control. This gene decreased 22.1 times compared to the control at week 4. Signal-regulatory protein beta 1B (Sirpb1b) and keratin 8 also displayed higher expression (more than 100 times) than the control at week 1, then subsequently decreased (expression: 4 and 16 times higher than the control, respectively) at week 4. The overall up- and downregulated genes and fold-change values of rotator cuff tear/control at weeks 1 and 4 are listed in [Table 2](#tab2){ref-type="table"}.

3.1. Gene Expression Patterns in the Aging Category {#sec3.1}
---------------------------------------------------

Analysis of the up- and downregulated genes in the 10 categories showed that insulin-like growth factor binding protein 2 (Igfbp2) was the most highly expressed gene in the aging category. It displayed 55.7 times higher expression in the RC tear side than in the control at week 1, and subsequently showed a decreasing trend (expressed 5.2 times higher than control) at week 4. In the string network which depicts the interactions between genes, we observed that IL6, Ccl2, and Vcam1, which are known to be related to inflammation or cell adhesion, actively interacted with each other showing high expression at week 1 after the RC tear. In addition, RAD54L (a DNA repair-related gene) and cyclin-dependent kinase 1 (Cdk1; a cell cycle regulation-related gene) also interacted closely ([Figure 4](#fig4){ref-type="fig"}). The top 10 up- and downregulated genes in the aging category at weeks 1 and 4 after the RC tear are listed in [Table 3](#tab3){ref-type="table"}.

3.2. Gene Expression Patterns in the Apoptosis Category {#sec3.2}
-------------------------------------------------------

In the apoptosis category, keratin 18 showed the highest expression (217.8 times higher expression than the control group) at week 1. This expression subsequently decreased (22 times higher expression than the control group) at week 4 ([Figure 5](#fig5){ref-type="fig"} and [Table 4](#tab4){ref-type="table"}). Interestingly, Birc5 (55.6 and 1.6 times higher expression than control at weeks 1 and 4, respectively), Rps6ka2 (0.2 times and 0.5 times higher expression than control at weeks 1 and 4, respectively), and Bub1 (37.5 and 0.3 times higher expression than control at weeks 1 and 4, respectively), which also showed reverse expression patterns, presented active interactions with each other revealed by the STRING network analysis results of week 1. These genes are known to be involved in apoptotic processes, such as cell growth, cell cycle, and cell differentiation.

3.3. Gene Expression Patterns in the Muscle Atrophy Category {#sec3.3}
------------------------------------------------------------

Among the 39,429 genes analyzed, a total of 11 genes belonged to the muscle atrophy category ([Figure 6](#fig6){ref-type="fig"} and [Table 5](#tab5){ref-type="table"}). Myog (myogenin), which is associated with myogenesis, showed the highest expression at week 1. In contrast, Mstn (myostatin), which is to inhibit myogenesis, showed the lowest expression at week 1. Further, Actin 3 (actin alpha 3), which is coexpressed with myostatin, also showed low expression at week 1 but a high expression at week 4 together with myostatin. This result was in contrast to that of myogenin, which showed the highest expression at week 1 but low expression at week 4.

3.4. Gene Expression Patterns in the Fatty Acid Transport Category {#sec3.4}
------------------------------------------------------------------

In the fatty acid transport category, the expression of apolipoprotein E (ApoE; expressed 12.229 times higher than control at week 1), annexin A1 (expressed 5.517 times higher than control at week 1) which is a phospholipid-binding protein, and perilipin 2 (expressed 5.018 times higher than control at week 1) which is an adipose differentiation-related gene was notable. The expression of all these genes decreased at week 4 (ApoE, annexin A1, and perilipin 2 were expressed 2.729, 1.377, and 1.196 times higher than control, respectively). In addition, these genes interacted with the phospholipase groups regulating PPAR*γ* expression, which regulates fatty acid storage and glucose metabolism, at weeks 1 and 4 as shown in the STRING network ([Figure 7](#fig7){ref-type="fig"} and [Table 6](#tab6){ref-type="table"}).

3.5. Gene Expression Patterns in Other Categories Related to Muscle Physiology {#sec3.5}
------------------------------------------------------------------------------

Gene expression patterns and STRING networks for other categories, such as angiogenesis, inflammation, cell migration, cell proliferation, extracellular matrix, and cell differentiation, are described in 'Supplementary Materials ([available here](#supplementary-material-1){ref-type="supplementary-material"})\'.

3.6. Validation of Gene Expression Using Real-Time PCR Analysis {#sec3.6}
---------------------------------------------------------------

Cdk1 from the aging category, keratin 8 and 18 from the apoptosis category, and myogenin, myostatin, and actn3 from the muscle atrophy category were selected as representative genes for the validation of gene expression using quantitative real-time PCR analysis. The result of qRT-PCR analyses for all these selected genes was similar to the result of microarray analysis discussed above. The mRNA levels from both microarray and qRT-PCR analyses are depicted in [Figure 8](#fig8){ref-type="fig"}.

3.7. Commonly Expressed Genes {#sec3.7}
-----------------------------

There were 2 common genes, namely, Rps6kb1 and gelsolin, which displayed commonly regulated expressions in the 3 categories (aging, apoptotic process, and muscle atrophy) of our interest that are known to be associated with muscle degeneration and atrophy after a rotator cuff tear. Rps6kb1 in the rotator cuff tear side was downregulated (expressed 0.48 times of the control) during the acute phase, and showed increased expression during the chronic phase (expressed 0.806 times of the control). In addition, Gelsolin in the rotator cuff tear side was also downregulated (0.40 times of the control) during the acute phase and showed increased expression during the chronic phase (expressed 1.17 times of the control).

4. Discussion {#sec4}
=============

The major findings of this study were comprehensive analysis of genetic changes with time following a rotator cuff tear and categorization of those genes associated with 10 muscle physiology, including aging, apoptosis, atrophy, and fatty acid transport.

We regarded week 1 as the acute phase and week 4 as the chronic phase, based on our previous study using the same animal model \[[@B10]\]. In our previous study, we detected acute inflammatory reactions in the rotator cuff muscle with a rapid increase in inflammatory cytokines at week 1; however, the inflammatory reactions almost disappeared 4 weeks after inducing the rotator cuff tear. Conversely, fat deposition with degenerative changes in the rotator cuff muscle started increasing during week 2 and a noticeable increase was observed 4 weeks after the rotator cuff tear \[[@B10]\]. Based on these findings, we defined week 1 after the rotator cuff tear as the acute phase and week 4 as the chronic phase.

Among a total of 39,429 genes, the gene that showed the highest increase in expression (expressed 217.7 times higher than the control) at week 1 after the rotator cuff tear was Krt18, which plays an important role in maintaining cell structure and is a major component of the intermediate filaments of epithelial cells \[[@B30]\]. It is also well-known to be an indicator of the progression of chronic liver diseases because it is related to apoptosis \[[@B31]\]. In the present study, a rapid increase in Krt18 expression was found during the acute phase after inducing the rotator cuff tear. We considered that the natural apoptotic process in muscle cells started considerably early after the rotator cuff tear, and if the apoptotic process progressed faster than the restoration process of damaged myocytes, a permanent and irreversible damage to the rotator cuff muscle may occur and the outcome may be worse even after a successful rotator cuff repair.

In the aging category, among all genes, the expression of lgfbp2 (insulin-like growth factor binding protein 2) was the highest at week 1 after the rotator cuff tear. This suggested that the muscle damage induced by the rotator cuff tear affected the aging process of myocytes. Davalos et al. showed that the IGF-binding proteins were highly expressed in aged fibroblast cells, which supported our results \[[@B32]\]. Particularly, IL-6 and Ccl2, which are adhesion molecules known to be secreted from aged cells, and Vcam1 interacted with each other and showed high expression as shown in the STRING network. In the apoptosis category, Birc5 (baculoviral IAP repeat-containing 5), which is known to be a survivin like krt 18, significantly increased (expressed 55.6 times of the control) during the acute phase. This survivin is known to influence cell division and cause cell death inhibition. Hence, it is related to tissue injury and healing \[[@B33]\]. In addition, this gene interacts with Rps6ka2 \[[@B34]\], which is related to cell survival; caspase 14 \[[@B35]\] and Cdk1 \[[@B36]\], which play important roles in cell growth and apoptosis; and MELK \[[@B37]\], which is related to cell proliferation, apoptosis, RNA processing, and embryonic development. Birc5, which is known to play an important role in apoptosis, seemed to play a similar role in the rotator cuff muscle after the rotator cuff tear. Only 11 among the 39,429 genes analyzed belonged to the muscle atrophy category. Among these, Myog (myogenin), which is known to play an important role in the differentiation of myocytes, showed the highest expression during the acute phase after rotator cuff tear as expected. On the contrary, Mstn (myostatin), which is known to play an inhibitory role during myogenesis, exhibited the lowest expression. These results suggested that myogenin rapidly increases during the early phase after the rotator cuff tear in order to regenerate damaged muscles (with low myostatin expression) and decreases as muscle atrophy and degeneration progressed with time. It was interesting that Gatm (L-arginine: glycine amidinotransferase), which is known to be related to obesity associated with creatine metabolism \[[@B38]\], showed the highest expression after myogenin. In addition, two new genes, namely, Cflar and Ppargc1a, which showed reverse patterns of expression between the acute and chronic phases (Cflar: CASP8 and FADD-like apoptosis regulator, expression decreased from 2.442 times during the acute phase to 0.935 times during the chronic phase; Ppargc1a, expression changed from 0.216 times during the acute phase to 0.763 times during the chronic phase), although not significant, can be studied as novel targets associated with changes in muscle atrophy after rotator cuff tear or repair. In the fatty acid transport category, the expression of ApoE (Apolipoprotein E) was noticeable. ApoE is known to play a pivotal role in lipid homeostasis \[[@B39]\], and was also highly expressed among the cell proliferation category genes. This gene can be analyzed in future studies for understanding its role in the reversal of fatty infiltration after rotator cuff repair. In this study, we observed two genes (Rps6kb1 and gelsolin) which showed common expression patterns across 3 categories, namely aging, apoptosis, and muscle atrophy. Rps6kb1 is known to play an important role in anabolic signaling by increasing lipid accumulation in the adipose tissue and inducing skeletal muscle hypertrophy \[[@B40]\], whereas gelsolin is known to be a physiological effector of apoptotic morphological changes after being cleaved by caspase 3 \[[@B41]\]. In this study, low expression of Rps6kb1 during the acute phase (expressed 0.48 times of the control) and high expression during the chronic phase (expressed 0.81 times of the control) suggested muscle damage recovery over time. Conversely, low expression of gelsolin during the acute phase (expressed 0.40 times of the control) and increased expression during the chronic phase (expressed 1.17 times of the control) potentially indicates ongoing apoptotic processes in rotator cuff muscles against the force to restore the damaged muscle. These two key genes may link and control muscle degeneration and sarcopenia after the rotator cuff tear.

The strength of our study is that this is the first study which comprehensively analyzed time-dependent expression of genes belonging to different categories associated with muscle physiology after making a rotator cuff tear. This finding may help to understand the rotator cuff tear-related muscle changes and, further it may improve various detrimental outcomes of rotator cuff repair surgery by regulation of the potent key molecule or its signal pathway.

Nevertheless, this study has several limitations that require consideration. First, this study was an animal-based study. Differences in anatomic features, different injury and healing reactions, and genetic variations between humans and rats limit generalization of the results. In this study, we established rotator cuff tear (RCT) model by injuring supraspinatus to make the most similar condition to the real clinical situation because most tears occur in the supraspinatus tendon in clinical situation. However, we humbly admit that 2 tendons (supraspinatus + infraspinatus) tear model may be better to mimic the muscle degenerative changes compared to the 1 tendon model, and there could exist a likelihood of self-healing in a mouse supraspinatus tear model. Thus, we have to be cautious while interpretation of results. Second, we investigated gene expression patterns in the rotator cuff muscles up to 4 weeks after making the tear, based on the results of our previous study \[[@B10]\]; however, there can be more biological and genetic changes during later time points (more than 4 weeks). Finally, molecular pathways underlying changes in muscle physiology after a rotator cuff tear were not identified in this study. This should be the next step of the study.

5. Conclusions {#sec5}
==============

\(i\) Rotator cuff tear induces specific genes associated with changes in muscle physiology such as aging, apoptosis, muscle atrophy, and fatty acid transport.

\(ii\) Several genes which are significantly altered after rotator cuff tear may play key roles in controlling muscle degeneration after a rotator cuff tear.

\(iii\) Mouse rotator cuff tear model could be a good approach to understand the many aspects of the molecular changes in injured muscle.

This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT \[NRF-2017R1D1A1B03033758 to Y.-S. Lee and NRF-2017R1A2B4003343 to S. W. Chung\].

Data Availability
=================

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest
=====================

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Supplementary Materials {#supplementary-material-1}
=======================

###### 

"Supplementary Figures" and "Supplementary Table" show gene expression patterns and the top 10 up- and downregulated genes in an additional muscle physiology-related category after rotator cuff tear, respectively.

###### 

Click here for additional data file.

![Information for interpreting the STRING network.](BMRI2018-5859013.001){#fig1}

![Percentages of total significant genes and up and down significant genes according to 10 categories after rotator cuff tear at (a) 1 and (b) 4 weeks.](BMRI2018-5859013.002){#fig2}

![Venn diagram depicting the number of genes up-, down-, and contraregulated among the significant genes for weeks 1 and 4.](BMRI2018-5859013.003){#fig3}

![Differential expression patterns in hierarchical clustering and the STRING network for the aging category ((a) week 1 after tear; (b) week 4 after tear). Left side shows differential expression patterns and hierarchical clustering, and right side shows the STRING network for the aging category.](BMRI2018-5859013.004){#fig4}

![Differential expression patterns in hierarchical clustering and the STRING network for the apoptosis category ((a) week 1 after tear; (b) week 4 after tear).](BMRI2018-5859013.005){#fig5}

![Differential expression patterns in hierarchical clustering and the STRING network for the muscle atrophy category ((a) week 1 after tear; (b) weeks 4 after tear).](BMRI2018-5859013.006){#fig6}

![Differential expression patterns in hierarchical clustering and the STRING network for the fatty acid transport category ((a) week 1 after tear; (b) week 4 after tear).](BMRI2018-5859013.007){#fig7}

![Validation of microarray gene expression patterns using qRT-PCR analysis. (a) Cdk1, (b) keratin 8, (c) keratin 18, (d) myogenin, (e) myostatin, and (f) actn3.](BMRI2018-5859013.008){#fig8}

###### 

Summary of the rotator cuff tear-induced expression for genes belonging to 10 categories at (a) 1 and (b) 4 weeks.

                            Total        10 categories associated with muscle physiology                                                                                    
  ------------------------- ------------ ------------------------------------------------- --------- --------- ----------- --------- --------- --------- --------- -------- --------
  1 week                    Total        Aging                                             Angio.    Apop.     Diff.       Migr.     Prolif.   ECM       Infl.     FA tr.   Atro
                                                                                                                                                                            
  Total gene number         39,429       370                                               443       1,100     4,701       994       788       683       532       66       19
                                                                                                                                                                            
  \% of Total               100          0.94                                              1.12      2.79      11.92       2.52      2         1.73      1.35      0.17     0.05
                                                                                                                                                                            
  Up significant (n)        8,662        127                                               174       378       1,422       386       262       264       249       10       3
                                                                                                                                                                            
  \% of Up significant      22           34.3                                              39.3      34.4      30.2        38.8      33.2      38.7      46.8      15.2     15.8
                                                                                                                                                                            
  Down significant (n)      3,516        40                                                30        113       436         75        45        54        31        13       9
                                                                                                                                                                            
  \% of Down significant    8.9          10.8                                              6.8       10.3      9.3         7.5       5.7       7.9       5.8       19.7     47.4
                                                                                                                                                                            
  Total significant (n)     **12,178**   **184**                                           **203**   **525**   **1,867**   **463**   **300**   **267**   **278**   **23**   **11**
                                                                                                                                                                            
  \% of Total significant   30.9         45.1                                              46        44.6      39.5        46.4      39        46.6      52.6      34.8     63.2

                            Total       10 categories associated with muscle physiology                                                                             
  ------------------------- ----------- ------------------------------------------------- -------- -------- --------- -------- --------- -------- -------- -------- -------
  4 weeks                   Total       Aging                                             Angio.   Apop.    Diff.     Migr.    Prolif.   ECM      Infl.    FA tr.   Atro
                                                                                                                                                                    
  Total gene number         39,429      370                                               443      1,100    4,701     994      788       683      532      66       19
                                                                                                                                                                    
  \% of Total               100         0.94                                              1.12     2.79     11.92     2.52     2         1.73     1.35     0.17     0.05
                                                                                                                                                                    
  Up Significant (n)        1,233       21                                                20       52       203       59       35        31       46       2        1
                                                                                                                                                                    
  \% of Up Significant      3.1         5.7                                               4.5      4.7      4.3       5.9      4.4       4.5      8.6      3        5.3
                                                                                                                                                                    
  Down Significant (n)      1,137       8                                                 9        34       150       31       32        12       15       0        4
                                                                                                                                                                    
  \% of Down Significant    2.9         2.2                                               2        3.1      3.2       3.1      4.1       1.8      2.8      0        21.1
                                                                                                                                                                    
  Total Significant (n)     **2,370**   **29**                                            **29**   **86**   **353**   **90**   **67**    **43**   **61**   **2**    **5**
                                                                                                                                                                    
  \% of Total Significant   6           7.8                                               6.5      7.8      7.5       9.1      8.5       6.3      11.5     3        26.3

Angio., angiogenesis; Apop., apoptosis; Diff., cell differentiation; Migr., cell migration; Prolif., cell proliferation; ECM, extracellular matrix; Infl., inflammation; FA tr., fatty acid transport; Atro., muscle atrophy.

Up significant means the genes with the fold change of rotator cuff tear/control of more than 2 the raw values (log2) of more than 4.

Down significant means the genes with the fold change of rotator cuff tear/control of less than 1/2 with the raw values (log2) of more than 4.

###### 

The top 10 up- and downregulated genes after rotator cuff tear (at weeks 1 and 4).

  Gene symbol     Genbank accession   Fold change   Gene name
  --------------- ------------------- ------------- ------------------------------------------------------------------------------
  Upregulated                                       
                                                    
  Krt18           NM_010664           217.799       keratin 18
                                                    
  Sirpb1b         NM_001173460        150.129       signal-regulatory protein beta 1B
                                                    
  Cd300lf         NM_001169153        128.186       CD300 antigen like family member F
                                                    
  Ms4a4c          NM_029499           122.342       membrane-spanning 4-domains, subfamily A, member 4C
                                                    
  Plekhh1         NM_181073           119.491       pleckstrin homology domain containing, family H (with MyTH4 domain) member 1
                                                    
  Cd5l            NM_009690           104.575       CD5 antigen-like
                                                    
  Krt8            AK166854            104.209       keratin 8
                                                    
  Myh8            AK081482            95.091        myosin, heavy polypeptide 8, skeletal muscle, perinatal
                                                    
  LOC102642410    XM_006544504        94.351        tyrosine-protein phosphatase non-receptor type substrate 1-like
                                                    
  Myh3            NM_001099635        92.621        myosin, heavy polypeptide 3, skeletal muscle, embryonic
                                                    
  Downregulated                                     
                                                    
  Pitx1           NM_011097           0.025         paired-like homeodomain transcription factor 1
                                                    
  Adam28          NM_183366           0.025         a disintegrin and metallopeptidase domain 28
                                                    
  Rnf180          NM_027934           0.027         ring finger protein 180
                                                    
  Gm5860          NR_040659           0.029         predicted gene 5860
                                                    
  H2-M9           NM_008205           0.03          histocompatibility 2, M region locus 9
                                                    
  Smco1           NM_183283           0.03          single-pass membrane protein with coiled-coil domains 1
                                                    
  AU042410        BB209673            0.031         expressed sequence AU042410
                                                    
  Kcnc1           NM_001112739        0.031         potassium voltage gated channel, Shaw-related subfamily, member 1
                                                    
  8430426J06Rik   NR_077229           0.032         RIKEN cDNA 8430426J06 gene
                                                    
  Gm10822         AK144860            0.033         predicted gene 10822

  Gene symbol     Genbank accession   Fold change   Gene name
  --------------- ------------------- ------------- ------------------------------------------------------------------------------
  Upregulated                                       
                                                    
  Gm7325          NM_001177470        45.121        predicted gene 7325
                                                    
  Plekhh1         NM_181073           42.051        pleckstrin homology domain containing, family H (with MyTH4 domain) member 1
                                                    
  Ces2b           NM_198171           28.227        carboxylesterase 2B
                                                    
  Ces2c           NM_145603           25.457        carboxylesterase 2C
                                                    
  Sln             NM_025540           24.155        sarcolipin
                                                    
  Krt18           NM_010664           22.114        keratin 18
                                                    
  Myh3            NM_001099635        17.984        myosin, heavy polypeptide 3, skeletal muscle, embryonic
                                                    
  Krt8            AK166854            16.550        keratin 8
                                                    
  Zfp735          NM_001126489        15.836        zinc finger protein 735
                                                    
  Epha1           NM_023580           15.534        Eph receptor A1
                                                    
  Downregulated                                     
                                                    
  Dok6            NM_001039173        0.063         docking protein 6
                                                    
  Snhg11          NM_175692           0.072         small nucleolar RNA host gene 11
                                                    
  Olfr981         NM_146286           0.087         olfactory receptor 981
                                                    
  Pitx1           NM_011097           0.087         paired-like homeodomain transcription factor 1
                                                    
  Gm12            NM_001195544        0.093         predicted gene 12
                                                    
  Olfr586         NM_147111           0.098         olfactory receptor 586
                                                    
  Samd11          XR_881429           0.101         sterile alpha motif domain containing 11
                                                    
  Dnase1          NM_010061           0.111         deoxyribonuclease I
                                                    
  1190003K10Rik   NM_001195435        0.114         RIKEN cDNA 1190003K10 gene
                                                    
  Gpr176          NM_201367           0.117         G protein-coupled receptor 176

###### 

Gene expression patterns after rotator cuff tear in the aging category ((a) week 1 after tear; (b) week 4 after tear).

  Gene symbol     Genbank accession   Fold change   Gene name
  --------------- ------------------- ------------- -------------------------------------------------------------------------
  Upregulated                                       
                                                    
  Igfbp2          NM_008342           55.685        insulin-like growth factor binding protein 2
                                                    
  Arg1            NM_007482           54.973        arginase, liver
                                                    
  Cdk1            NM_007659           34.242        cyclin-dependent kinase 1
                                                    
  Cdkn2a          NM_009877           30.112        cyclin-dependent kinase inhibitor 2A
                                                    
  Aldh3a1         NM_007436           19.548        aldehyde dehydrogenase family 3, subfamily A1
                                                    
  Ddc             NM_001190448        17.423        dopa decarboxylase
                                                    
  Ccl2            NM_011333           16.814        chemokine (C-C motif) ligand 2
                                                    
  Inpp5d          NM_010566           15.961        inositol polyphosphate-5-phosphatase D
                                                    
  Mpo             NM_010824           14.836        myeloperoxidase
                                                    
  Rad54l          NM_009015           13.26         RAD54 like (*S. cerevisiae*)
                                                    
  Downregulated                                     
                                                    
  Tfcp2l1         NM_023755           0.125         transcription factor CP2-like 1
                                                    
  Nat1            NM_008673           0.146         N-acetyl transferase 1
                                                    
  Ppargc1a        NM_008904           0.153         peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
                                                    
  Atp8a2          NM_015803           0.157         ATPase, aminophospholipid transporter-like, class I, type 8A, member 2
                                                    
  Pde4d           NM_011056           0.183         phosphodiesterase 4D, cAMP specific
                                                    
  Endog           NM_007931           0.195         endonuclease G
                                                    
  Cyp1a1          NM_009992           0.199         cytochrome P450, family 1, subfamily a, polypeptide 1
                                                    
  Kl              NM_013823           0.2           klotho
                                                    
  Cryab           NM_001289782        0.21          crystallin, alpha B
                                                    
  P2ry1           NM_008772           0.216         purinergic receptor P2Y, G-protein coupled 1

  Gene symbol     Genbank accession   Fold change   Gene name
  --------------- ------------------- ------------- -------------------------------------------------------------------------------
  Upregulated                                       
                                                    
  Slc1a2          NM_001077514        10.851        solute carrier family 1 (glial high affinity glutamate transporter), member 2
                                                    
  Krtap4-16       NM_001013823        9.991         keratin associated protein 4-16
                                                    
  Ghrhr           NM_001003685        9.285         growth hormone releasing hormone receptor
                                                    
  Ddc             NM_001190448        8.068         dopa decarboxylase
                                                    
  Aldh3a1         NM_007436           7.897         aldehyde dehydrogenase family 3, subfamily A1
                                                    
  Cdkn2a          NM_009877           6.885         cyclin-dependent kinase inhibitor 2A
                                                    
  Igfbp2          NM_008342           5.164         insulin-like growth factor binding protein 2
                                                    
  Retn            NM_001204959        3.729         resistin
                                                    
  Adra1a          NM_013461           3.523         adrenergic receptor, alpha 1a
                                                    
  Cnr1            NM_007726           3.51          cannabinoid receptor 1 (brain)
                                                    
  Downregulated                                     
                                                    
  Il10            NM_010548           0.195         interleukin 10
                                                    
  Cdk1            NM_007659           0.227         cyclin-dependent kinase 1
                                                    
  Glrx2           NM_001038592        0.325         glutaredoxin 2 (thioltransferase)
                                                    
  Tfcp2l1         NM_023755           0.391         transcription factor CP2-like 1
                                                    
  Fos             NM_010234           0.438         FBJ osteosarcoma oncogene
                                                    
  Atp8a2          NM_015803           0.459         ATPase, aminophospholipid transporter-like, class I, type 8A, member 2
                                                    
  Hmga1           NM_001166546        0.462         high mobility group AT-hook 1
                                                    
  Bcl2            NM_177410           0.464         B-cell leukemia/lymphoma 2
                                                    
  Srf             NM_020493           0.482         serum response factor
                                                    
  Arntl           NM_007489           0.519         aryl hydrocarbon receptor nuclear translocator-like

###### 

Gene expression patterns in the apoptosis category after rotator cuff tear ((a) week 1 after tear; (b) week 4 after tear).

  Gene symbol     Genbank accession   Fold change   Gene name
  --------------- ------------------- ------------- --------------------------------------------------------------
  Upregulated                                       
                                                    
  Krt18           NM_010664           217.799       keratin 18
                                                    
  Cd5l            NM_009690           104.575       CD5 antigen-like
                                                    
  Krt8            AK166854            104.209       keratin 8
                                                    
  Serpina3g       NM_009251           85.473        serine (or cysteine) peptidase inhibitor, clade A, member 3G
                                                    
  Melk            NM_010790           72.784        maternal embryonic leucine zipper kinase
                                                    
  Birc5           NM_009689           55.603        baculoviral IAP repeat-containing 5
                                                    
  Gpr65           NM_008152           54.323        G-protein coupled receptor 65
                                                    
  Gzma            NM_010370           52.943        granzyme A
                                                    
  Top2a           NM_011623           44.234        topoisomerase (DNA) II alpha
                                                    
  Bcl2a1d         NM_007536           43.608        B-cell leukemia/lymphoma 2-related protein A1d
                                                    
  Downregulated                                     
                                                    
  Dnase1          NM_010061           0.051         deoxyribonuclease I
                                                    
  Casp14          NM_009809           0.099         caspase 14
                                                    
  Robo2           BC055333            0.104         roundabout homolog 2 (*Drosophila*)
                                                    
  Camk2a          NM_009792           0.107         calcium/calmodulin-dependent protein kinase II alpha
                                                    
  Il24            NM_053095           0.112         interleukin 24
                                                    
  Chac1           NM_026929           0.119         ChaC, cation transport regulator 1
                                                    
  Nr4a1           NM_010444           0.122         nuclear receptor subfamily 4, group A, member 1
                                                    
  Mtfp1           NM_026443           0.124         mitochondrial fission process 1
                                                    
  Rps6ka2         NM_011299           0.156         ribosomal protein S6 kinase, polypeptide 2
                                                    
  Casr            NM_013803           0.158         calcium-sensing receptor

  Gene symbol     Genbank accession   Fold change   Gene name
  --------------- ------------------- ------------- -------------------------------------------------------------------
  Upregulated                                       
                                                    
  Krt18           NM_010664           22.114        keratin 18
                                                    
  Krt8            AK166854            16.55         keratin 8
                                                    
  Bcl2l14         NM_025778           14.994        BCL2-like 14 (apoptosis facilitator)
                                                    
  Tox3            NM_172913           10.794        TOX high mobility group box family member 3
                                                    
  Fasl            NM_010177           10.487        Fas ligand (TNF superfamily, member 6)
                                                    
  Pak7            NM_172858           9.86          p21 protein (Cdc42/Rac)-activated kinase 7
                                                    
  Fgf21           NM_020013           7.87          fibroblast growth factor 21
                                                    
  Avp             NM_009732           7.557         arginine vasopressin
                                                    
  Nlrc4           NM_001033367        7.471         NLR family, CARD domain containing 4
                                                    
  Cdkn2a          NM_009877           6.885         cyclin-dependent kinase inhibitor 2A
                                                    
  Downregulated                                     
                                                    
  Dnase1          NM_010061           0.111         deoxyribonuclease I
                                                    
  Cd27            NM_001033126        0.117         CD27 antigen
                                                    
  Fgf8            NM_010205           0.162         fibroblast growth factor 8
                                                    
  AY074887        NM_145229           0.168         cDNA sequence AY074887
                                                    
  Tnf             NM_013693           0.205         tumor necrosis factor
                                                    
  Naip1           NM_008670           0.217         NLR family, apoptosis inhibitory protein 1
                                                    
  Cdk1            NM_007659           0.227         cyclin-dependent kinase 1
                                                    
  Epha7           NM_010141           0.239         Eph receptor A7
                                                    
  Tiam1           NM_009384           0.253         T-cell lymphoma invasion and metastasis 1
                                                    
  Bub1            NM_009772           0.284         budding uninhibited by benzimidazoles 1 homolog (*S. cerevisiae*)

###### 

Gene expression patterns in the muscle atrophy category after rotator cuff tear ((a) week 1 after tear; (b) week 4 after tear).

  Gene symbol     Genbank accession   Fold change   Gene name
  --------------- ------------------- ------------- ------------------------------------------------------------------------------------------------
  Upregulated                                       
                                                    
  Myog            NM_031189           38.535        myogenin
                                                    
  Gatm            NM_025961           8.862         glycine amidinotransferase (L-arginine:glycine amidinotransferase):energy metabolism of muscle
                                                    
  Cflar           NM_009805           2.442         CASP8 and FADD-like apoptosis regulator
                                                    
  Rps6kb1         NM_028259           1.287         ribosomal protein S6 kinase, polypeptide 1
                                                    
  Downregulated                                     
                                                    
  Il15            NM_008357           0.727         interleukin 15
                                                    
  Tbce            NM_178337           0.648         tubulin-specific chaperone E
                                                    
  Gsn             NM_146120           0.439         Gelsolin:actin-binding protein
                                                    
  Trim63          NM_001039048        0.435         tripartite motif-containing 63
                                                    
  Actn3           NM_013456           0.279         actinin alpha 3:alpha-actinin skeletal muscle isoform 3
                                                    
  Ppargc1a        NM_008904           0.216         peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
                                                    
  Mstn            NM_010834           0.108         myostatin

  Gene symbol     Genbank accession   Fold change   Gene name
  --------------- ------------------- ------------- -------------------------------------------------------------------------
  Upregulated                                       
                                                    
  Myog            NM_031189           11.945        myogenin
                                                    
  Gatm            NM_025961           1.712         glycine amidinotransferase (L-arginine:glycine amidinotransferase)
                                                    
  Gsn             NM_146120           1.249         gelsolin
                                                    
  Rps6kb1         NM_028259           1.245         ribosomal protein S6 kinase, polypeptide 1
                                                    
  Downregulated                                     
                                                    
  Il15            NM_008357           0.98          interleukin 15
                                                    
  Cflar           NM_207653           0.935         CASP8 and FADD-like apoptosis regulator
                                                    
  Ppargc1a        NM_008904           0.763         peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
                                                    
  Tbce            NM_178337           0.712         tubulin-specific chaperone E
                                                    
  Actn3           NM_013456           0.494         actinin alpha 3
                                                    
  Trim63          NM_001039048        0.387         tripartite motif-containing 63
                                                    
  Mstn            NM_010834           0.378         myostatin

###### 

Gene expression patterns in the fatty acid transport category after rotator cuff tear ((a) week 1 after tear; (b) week 4 after tear).

  Gene symbol     Genbank accession   Fold change   Gene name
  --------------- ------------------- ------------- -------------------------------------------------------------
  Upregulated                                       
                                                    
  Mfsd2a          NM_029662           12.606        major facilitator superfamily domain containing 2A
                                                    
  Apoe            NM_009696           12.229        apolipoprotein E
                                                    
  Drd4            NM_007878           10.607        dopamine receptor D4
                                                    
  Slc27a6         NM_001081072        7.557         solute carrier family 27 (fatty acid transporter), member 6
                                                    
  Pla2g4a         NM_008869           6.457         phospholipase A2, group IVA (cytosolic, calcium-dependent)
                                                    
  Anxa1           NM_010730           5.517         annexin A1
                                                    
  Plin2           NM_007408           5.018         perilipin 2
                                                    
  Pla2g2e         NM_012044           3.407         phospholipase A2, group IIE
                                                    
  Pla2g1b         NM_011107           3.384         phospholipase A2, group IB, pancreas
                                                    
  Hnf1a           M57966              2.029         HNF1 homeobox A
                                                    
  Downregulated                                     
                                                    
  Fabp3           NM_010174           0.131         fatty acid binding protein 3, muscle and heart
                                                    
  Pla2g5          NM_001122954        0.15          phospholipase A2, group V
                                                    
  Cpt1b           NM_009948           0.186         carnitine palmitoyltransferase 1b, muscle
                                                    
  Pla2g12a        NM_183423           0.262         phospholipase A2, group XIIA
                                                    
  Got2            NM_010325           0.289         glutamic-oxaloacetic transaminase 2, mitochondrial
                                                    
  Slc27a2         NM_011978           0.299         solute carrier family 27 (fatty acid transporter), member 2
                                                    
  Slc27a1         NM_011977           0.32          solute carrier family 27 (fatty acid transporter), member 1
                                                    
  Acsl1           NM_007981           0.354         acyl-CoA synthetase long-chain family member 1
                                                    
  Pnpla8          NM_026164           0.372         patatin-like phospholipase domain containing 8
                                                    
  Pla2g2c         NM_008868           0.408         phospholipase A2, group IIC

  -----------------------------------------------------------------------------------------------------------
  Gene symbol     Genbank accession   Fold change   Gene name
  --------------- ------------------- ------------- ---------------------------------------------------------
  Upregulated                                       

                                                    

  Nmur2           NM_153079           3.742         neuromedin U receptor 2

                                                    

  Apoe            NM_009696           2.729         apolipoprotein E

                                                    

  Pla2g2d         NM_011109           2.704         phospholipase A2, group IID

                                                    

  Pparg           NM_011146           1.56          peroxisome proliferator activated receptor gamma

                                                    

  Proca1          XM_006532963        1.548         protein interacting with cyclin A1

                                                    

  Pla2g2e         NM_012044           1.539         phospholipase A2, group IIE

                                                    

  Pla2g4a         NM_008869           1.485         phospholipase A2, group IVA\
                                                    (cytosolic, calcium-dependent)

                                                    

  Anxa1           NM_010730           1.377         annexin A1

                                                    

  Pla2g2a         NM_001082531        1.286         phospholipase A2,\
                                                    group IIA (platelets, synovial fluid)

                                                    

  Mfsd2a          NM_029662           1.268         major facilitator superfamily\
                                                    domain containing 2A

                                                    

  Downregulated                                     

                                                    

  Pla2g1b         NM_011107           0.428         phospholipase A2, group IB,\
                                                    pancreas

                                                    

  Slc27a5         NM_009512           0.456         solute carrier family 27 (fatty acid\
                                                    transporter),\
                                                    member 5

                                                    

  Pla2g3          NM_172791           0.511         phospholipase A2, group III

                                                    

  Hnf1a           M57966              0.529         HNF1 homeobox A

                                                    

  Fabp3           NM_010174           0.587         fatty acid-binding protein 3, muscle and heart

                                                    

  Pla2g2f         NM_012045           0.592         phospholipase A2, group IIF

                                                    

  Abcc4           NM_001033336        0.592         ATP-binding cassette, sub-family C (CFTR/MRP), member 4

                                                    

  Pnpla8          NM_026164           0.614         patatin-like phospholipase domain containing 8

                                                    

  Ppard           NM_011145           0.628         peroxisome proliferator activator receptor delta

                                                    

  Pla2g5          NM_001122954        0.661         phospholipase A2, group V
  -----------------------------------------------------------------------------------------------------------

[^1]: Academic Editor: Antonio Salgado
